logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
K

Kagawa University Hospital

Scholars14
Papers10
Citations101
Related Papers (10)
Publication Date
delete
Probio-M9 and Genetic Senolysis Attenuate Experimental Colitis by Targeting Inflammation-Associated Cellular Senescence
errEngineering
IF11.6
err2026-08-19
err0
errOAAI
errGaopeng Li; Zhixin Zhao; Feiyan Zhao; Masakazu Ishikawa; Kensuke Kumamoto; Kiyomi Ohmichi; Ryou Ishikawa; Satoshi Yamazaki; Zhihong Sun; Lin Hai Kurahara
errShare
errSave
Residual Platinum-Induced Neuropathy and the Feasibility of Second-Line Paclitaxel–Ramucirumab Therapy in Advanced Gastric Cancer: Prospective Multicenter Evidence from Japan
errCancers
IF4.4
err2026-08-18
err0
errOAAI
errTakeshi Nagasaka; Yoshiyasu Kono; Yosuke Kito; Takayuki Ando; Yuji Negoro; Tomoyuki Abe; Hidekazu Kuramochi; Shogen Boku; Tomohiko Mannami; Junichiro Nasu; Masafumi Inoue; Masato Nakamura; Yoshihiro Okita; Yoshiaki Shindo; Takeshi Yamada; Tetsuya Maeda; Yudai Shinohara; Hiroaki Tanioka
errShare
errSave
Preserved Acute Pulmonary Endothelial Homeostasis with Hydrogen Gas Inhalation After Neonatal Hypoxia–Ischemia Despite Increased Neutrophil Accumulation
errBiomedicines
IF3.9
err2026-07-30
err0
errOAAI
errTakayuki Yokota; Masumi Iketani; Toui Tsuchiya; Kosuke Sakamoto; Yasuhiro Nakao; Tsutomu Mitsuie; Eri Inoue; Kota Inoue; Tomoaki Kusaka; Takayuki Wakabayashi; Kosuke Koyano; Takanori Miki; Masaki Ueno; Shinji Nakamura; Takashi Kusaka
errShare
errSave
Association between hydrogen gas inhalation and cardiac output in an asphyxiated piglet model
errScientific Reports
IF3.9
err2026-01-14
err0
errOAAI
errKosuke Sakamoto; Shinji Nakamura; Toui Tsuchiya; Tsutomu Mitsuie; Yasuhiro Nakao; Yinmon Htun; Takayuki Yokota; Kota Inoue; Eri Inoue; Takayuki Wakabayashi; Aya Morimoto; Kosuke Koyano; Yukihiko Konishi; Takashi Iwase; Taikou Horii; Takashi Kusaka
errShare
errSave
Elucidation of mechanisms underlying the therapeutic effects of cordycepin on pulmonary hypertension, with a focus on cell senescence and gut microbiota
errBiomedicine & Pharmacotherapy
IF7.5
err2026-01-06
err0
errOAAI
errGaopeng Li; Zhixin Zhao; Mitsuhiro Machitani; Ryou Ishikawa; Kaori Ishikawa; Naoya Yokota; Reiji Haba; Kazufumi Nakamura; Zhihong Sun; Lin-Hai Kurahara; Katsuya Hirano
errShare
errSave
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer
errEuropean Urology Oncology
IF9.3
err2025-11-04
err0
errOAAI
errFred Saad; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Emma Brown; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; Elizabeth A. Harrington; Jinyu Kang; Noel Clarke
errShare
errSave
Lacticaseibacillus rhamnosus Probio-M9 Alters the Gut Microbiota and Mitigates Pulmonary Hypertension in a Rat Model
errNutrients 2025, Vol. 17, Page 2927
IF5
err2025-09-20
err0
errOAAI
errZhixin Zhao; Gaopeng Li; Kiyomi Ohmichi; Xiaodong Li; Feiyan Zhao; Kaori Ishikawa; Ryou Ishikawa; Kazufumi Nakamura; Naoya Yokota; Zhihong Sun; Lin Hai Kurahara
errShare
errSave
Association between conversion from an initial shockable rhythm to pulseless electrical activity before extracorporeal cardiopulmonary resuscitation and outcome -A secondary analysis of the SAVE-JⅡ study-
errAmerican Heart Journal
IF3.5
err2025-08-22
err0
PREAI
errShinichi Ijuin; Akihiko Inoue; Toru Hifumi; Takuya Taira; Taiki Moriyama; Masafumi Suga; Takeshi Nishimura; Tetsuya Sakamoto; Yasuhiro Kuroda; Satoshi Ishihara
errShare
errSave
Consideration of ethnic differences in approvals for anti-HIV medicines in Japan: Evaluation based on pharmacokinetic studies and post-marketing data
errBritish Journal of Clinical Pharmacology
IF3
err2025-05-29
err0
errOAAI
errRumiko Shimazawa; Masayuki Ikeda
errShare
errSave
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial
errEuropean Urology Oncology
IF9.3
err2024-10-01
err0
errOAAI
errNoel W. Clarke; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Francis Parnis; Emma Brown; Friederike Schlürmann; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; David McGuinness; Arnold Degboe; Fred Saad
errShare
errSave